• 1
    Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L. and Carroll, M. C., Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 1995. 92: 1149011494.
  • 2
    Sahu, A. and Lambris, J. D., Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 2001. 180: 3548.
  • 3
    Barrington, R., Zhang, M., Fischer, M. and Carroll, M. C., The role of complement in inflammation and adaptive immunity. Immunol. Rev. 2001. 180: 515.
  • 4
    Walport, M. J., Complement. First of two parts. N. Engl. J. Med. 2001. 344: 10581066.
  • 5
    Walport, M. J., Complement. Second of two parts. N. Engl. J. Med. 2001. 344: 11401144.
  • 6
    Watford, W. T., Ghio, A. J. and Wright, J. R., Complement-mediated host defense in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000. 279: 790798.
  • 7
    Prodeus, A. P., Zhou, X., Maurer, M., Galli, S. J. and Carroll, M. C., Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997. 390: 172175.
  • 8
    Circolo, A., Garnier, G., Fukuda, W., Wang, X., Hidvegi, T., Szalai, A. J., Briles, D. E., Volanakis, J. E., Wetsel, R. A. and Colten, H. R., Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 1999. 42: 135149.
  • 9
    Shapiro, S., Beenhouwer, D. O., Feldmesser, M., Taborda, C., Carroll, M. C., Casadevall, A. and Scharff, M. D., Immunoglobulin G monoclonal antibodies to Cryptococcus neoformans protect mice deficient in complement component C3. Infect. Immun. 2002. 70: 25982604.
  • 10
    Verschoor, A., Brockman, M. A., Knipe, D. M. and Carroll, M. C., Cutting edge: myeloid complement C3 enhances the humoral response to peripheral viral infection. J. Immunol. 2001. 167: 24462451.
  • 11
    Kopf, M., Abel, B., Gallimore, A., Carroll, M. and Bachmann,M. F., Complement component C3 promotes T cell priming and lung migration to control acute influenza virus infection. Nat. Med. 2002. 8: 373378.
  • 12
    Bohlson, S. S., Strasser, J. A., Bower, J. J. and Schorey, J. S., Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3. Infect. Immun. 2001. 69: 77297735.
  • 13
    Connolly, S. E. and Benach, J. L., Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-indpendent bactericidal antibodies. J. Immunol. 2001. 167: 30293032.
  • 14
    Drouin, S. M., Corry, D. B., Kildsgaard, J. and Wetsel, R. A., Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 2001. 167: 41414145.
  • 15
    van der Zee, A., Mooi, F., Van Embden, J. and Musser, J., Molecularevolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J. Bacteriol. 1997. 179: 66096617.
  • 16
    Kirimanjeswara, G. S., Mann, P. B. and Harvill, E. T., Role of antibodies in immunity to Bordetella infections. Infect. Immun. 2003. 71: 17191724.
  • 17
    Burns, V. C., Pishko, E. J., Preston, A., Maskell, D. J. and Harvill, E. T., Role of Bordetella O antigen in respiratory tract infection. Infect. Immun. 2003. 71: 8694.
  • 18
    Harvill, E. T., Cotter, P. A. and Miller, J. F., Pregenomic comparative analysis between Bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect. Immun. 1999. 67: 61096118.
  • 19
    von Konig, C. H., Halperin, S., Riffelmann, M. and Guiso, N., Pertussis of adults and infants. Lancet Infect. Dis. 2002. 2: 744750.
  • 20
    Watanabe, M. and Nagai, M., Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection. Infect. Immun. 2001. 69: 69816986.
  • 21
    Singer, L., Colten, H. R. and Wetsel, R. A., Complement C3 deficiency: human, animal, and experimental models. Pathobiology 1994. 62: 1428.
  • 22
    Sahu, A., Sunyer, J. O., Moore, W. T., Sarrias, M. R., Soulika, A. M. and Lambris, J. D., Structure, functions, and evolution of the third complement component and viral molecular mimicry. Immunol.Res. 1998. 17: 109121.
  • 23
    Ram, S., Cullinane, M., Blom, A. M., Gulati, S., McQuillen, D. P., Boden, R., Monks, B. G., O'Connell, C., Elkins, C., Pangburn, M. K., Dahlback, B. and Rice, P. A., C4 bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae. Int. Immunopharmacol. 2001. 1: 423432.
  • 24
    Apicella, M. A., Mandrell, R. E., Shero, M., Wilson, M. E., Griffiss, J. M., Brooks, G. F., Lammel, C., Breen, J. F. and Rice, P. A., Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J. Infect. Dis. 1990. 162: 506512.
  • 25
    Berggard, K., Johnsson, E., Mooi, F. R. and Lindahl, G., Bordetella pertussis binds the human complement regulator C4BP: role of filamentous hemagglutinin. Infect. Immun. 1997. 65: 36383643.
  • 26
    Brown, E. J., Joiner, K. A., Gaither, T. A., Hammer, C. H. and Frank, M. M., The interaction of C3b bound to pneumococci with factor H (beta 1H globulin), factor I (C3b/C4b inactivator), and properdin factor B of the human complement system. J. Immunol. 1983. 131: 409415.
  • 27
    China, B., Sory, M. P., N'Guyen, B. T., De Bruyere, M. and Cornelis, G. R., Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 1993.61: 31293136.
  • 28
    Corbi, A. L., Kishimoto, T. K., Miller, L. J. and Springer, T. A., The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J. Biol. Chem. 1988. 263: 1240312411.
  • 29
    Jones, S. L., Knaus, U. G., Bokoch, G. M. and Brown, E. J., Two signaling mechanisms for activation of alphaM beta2 avidity in polymorphonuclear neutrophils. J. Biol. Chem. 1998. 273: 1055610566.
  • 30
    Ishibashi, Y., Yoshimura, K., Nishikawa, A., Claus, S., Laudanna, C. and Relman, D. A., Role of phosphatidylinositol 3-kinase in the binding of Bordetella pertussis to human monocytes. Cell Microbiol. 2002. 4: 825833.
  • 31
    Cotter, P. A. and Miller, J. F., BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect. Immun. 1994. 62: 33813390.
  • 32
    Lu, H., Smith, C. W., Perrard, J., Bullard, D., Tang, L., Shappell, S. B., Entman, M. L., Beaudet, A. L. and Ballantyne, C. M., LFA-1 is sufficient in mediating neutrophil emigration in Mac-1-deficient mice. J. Clin. Invest 1997. 99: 13401350.
  • 33
    Hodge, L. M. and Simecka, J. W., Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease. J. Infect. Dis. 2002. 186: 290294.
  • 34
    Lindell, D. M., Standiford, T. J., Mancuso, P., Leshen, Z. J. and Huffnagle, G. B., Macrophage inflammatory protein 1alpha/CCL3 is required for clearance of an acute Klebsiella pneumoniae pulmonary infection. Infect.Immun. 2001. 69: 63646369.